China-based Bon Natural Life Limited (BON), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries has successfully developed new nutraceutical compounds, Glucoraphanin (GF) and Sulforaphane (SFN), both of which are compounds extracted from cruciferous vegetables that could potentially provide immunity support and improve certain other regulatory health functions. The Company plans to launch GF and SFN based consumer products in the next 6 months.
According to recent study led by John Hopkins University and published by Nature, both compounds are shown to have potential effect in inhibiting the infection of SARS-CoV-2, including Delta and Omicron.
BON has achieved cutting-edge technological breakthroughs in developing such products, including developing a proprietary GF separation platform and various GF based health supplement consumer products with long shelf life and building a high-efficiency SFN production line with proprietary technology to reduce gastrointestinal irritation. In addition, BON also plants the highest concentration cruciferous vegetables farm to improve the large-scale production.
It plans to launch the following health supplement products within the next 6 months via multiple sales channels, including direct sales to pharmacies and enterprises, e-commerce platforms and distributors. These products include:
- Immune system booster in soft gel capsules
- Digestive health booster in soft gel capsules
- Weight loss management products
- Sleep aid products for mid-aged and elderly.
Richard Hu, CEO and Chairman of BON said, “This marks another major milestone in our strategy to introduce proprietary products into new consumer markets. Thanks to the tremendous and decade-long efforts of our R&D team, we are excited and proud to be able to add health products that are new and innovative to our nutraceutical line on the solid foundation of our legacy compound business. In nearly all regions of the world, the population aged 65 and older is growing faster than the total population, challenging health companies and organisations worldwide. We look forward to bringing our products to the market and are optimistic about the market opportunity and revenue potential from our broccoli extracted nutraceutical products.”
